Michael S Perry's Net Worth
$16.3 Million
Who is Michael S Perry?
Michael S Perry has an estimated net worth of $16.3 Million. This is based on reported shares across multiple companies, which include Avita Therapeutics, Inc., ARROWHEAD PHARMACEUTICALS, INC., PONIARD PHARMACEUTICALS, INC., TARGETED GENETICS CORP /WA/, and Icon Development, Inc..
SEC CIK
Michael S Perry's CIK is 0001250379
Past Insider Trading and Trends
2020 was Michael S Perry's most active year for acquiring shares with 10 total transactions. Michael S Perry's most active month to acquire stocks was the month of April. 2020 was Michael S Perry's most active year for disposing of shares, totalling 13 transactions. Michael S Perry's most active month to dispose stocks was the month of August. 2022 saw Michael S Perry paying a total of $898,500.00 for 195,993 shares, this is the most they've acquired in one year. In 2019 Michael S Perry cashed out on 185,000 shares for a total of $5,440,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Avita Therapeutics, Inc. (RCEL) Snapshot price: $8.84
Chief Executive OfficerMichael S Perry owns 229,543 units of Common Stock which is worth $2,029,160.12. In the year 2020 Michael S Perry filed a total of 10 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$6.59 | -$178,500.00 | 229.54K |
Nov 21
| |||
Form 4
| +1.00% | 2.98K |
—
|
—
| 300.98K |
Sep 1
| |||
Form 4
| -7.38% | -23.75K |
—
|
—
| 297.96K |
Jun 1
| |||
Form 4
| +6.24% | 18.9K |
$8.74 | -$94,496.88 | 321.71K |
Feb 23 - Feb 24
| |||
Form 4
| +30.88% | 71.44K |
—
|
—
| 302.81K |
Dec 22
| |||
Form 4
| +5.57% | 12.53K |
$20.68 | -$232,029.60 | 237.64K |
Sep 1
| |||
Form 4
| -9.27% | -23.00K |
$17.33 | -$398,590.00 | 225.1K |
Jun 2
| |||
Form 4
| +5.10% | 20.64K |
$27.19 | -$1,301,252.95 | 425.09K |
Sep 14 - Sep 16
| |||
Form 4
| +16.14% | 56.2K |
$26.08 | -$707,581.28 | 404.44K |
Sep 9 - Sep 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Snapshot price: $22.22
InvestorMichael S Perry owns 114,754 units of Common Stock which is worth $2,549,833.88 and 90,000 units of Common Stock Sold which is worth $1,999,800.00. From 2012 to 2023 Michael S Perry acquired a total of 344,254 shares in ARROWHEAD PHARMACEUTICALS, INC. at a cost of $666,019.67, Michael also disposed a total of 229,500 shares of ARROWHEAD PHARMACEUTICALS, INC. equalling to $7,325,443.40.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +15.02% | 14.99K |
$25.41 | $380,819.67 | 114.75K |
Dec 15
| |||
Form 4
| +8.56% | 7.87K |
—
|
—
| 99.77K |
Jan 10
| |||
Form 4
| +7.49% | 6.4K |
—
|
—
| 91.9K |
Jan 7
| |||
Form 4
| -5.00% | -4.50K |
$64.71 | -$291,192.40 | 85.5K |
Scheduled
|
Jan 3
| ||
Form 4
| +2.79% | 5K |
$76.09 | -$304,360.00 | 184K |
Jan 1 - Jan 4
| |||
Form 4
| +962.50% | 77K |
$3.70 | $285,200.00 | 85K |
May 14
| |||
Form 4
| -81.82% | -36.00K |
$35.83 | -$1,289,891.00 | 8K |
May 12
| |||
Form 4
| +22.22% | 8K |
—
|
—
| 44K |
Jan 1
| |||
Form 4
| -83.71% | -185.00K |
$29.41 | -$5,440,000.00 | 36K |
Sep 9 - Sep 11
| |||
Form 4
| +19.46% | 36K |
—
|
—
| 221K |
Jan 1
| |||
Form 4
| +19.35% | 30K |
—
|
—
| 185K |
Jan 1
| |||
Form 4
| +106.67% | 80K |
—
|
—
| 155K |
Jan 1
| |||
Form 4
| +66.67% | 30K |
—
|
—
| 75K |
Jan 1
| |||
Form 4
| +200.00% | 30K |
—
|
—
| 45K |
Mar 4
| |||
Form 4
|
∞
| 15K |
—
|
—
| 15K |
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PONIARD PHARMACEUTICALS, INC. No price found
President & CMOMichael S Perry owns 10,519 units of Common Stock and 8,920 units of Common Stock (PARD). In the year 2010 Michael S Perry filed a total of 12 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -15.20% | -1.60K |
$0.83 | -$1,329.89 | 8.92K |
Mar 27
| |||
Form 4
| +36.27% | 2.8K |
—
|
—
| 10.52K |
Mar 26
| |||
Form 4
| -45.12% | -6.35K |
$0.87 | -$5,507.69 | 7.72K |
Feb 16
| |||
Form 4
| +587.44% | 12.02K |
—
|
—
| 14.06K |
Feb 15
| |||
Form 4
| -35.54% | -45.14K |
$0.37 | -$16,864.30 | 81.86K |
Apr 13
| |||
Form 4
| +746.67% | 112K |
—
|
—
| 127K |
Apr 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
| +100.00% | 7.5K |
—
|
—
| 15K |
Jul 30
| |||
Form 4
|
∞
| 7.5K |
—
|
—
| 7.5K |
Apr 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TARGETED GENETICS CORP /WA/ (ARMP) Snapshot price: $2.4
InvestorMichael S Perry owns 70,000 units of Common Stock which is worth $168,000.00.acquired a total of 70,000 shares in TARGETED GENETICS CORP /WA/.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
| +246.89% | 292.59K |
$1.10 |
—
| 411.11K |
Jun 29 - Mar 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +250.00% | 50K |
—
|
—
| 70K |
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
| +100.00% | 10K |
—
|
—
| 20K |
May 15
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Icon Development, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||